http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004083600-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d9f38dad6342df09dea6b5c21b73725
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S507-924
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E21B43-267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E21B43-267
filingDate 2004-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01e8ca2a33e3f93f81d2a3325af90d0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be28e35b39b399b35e467d8a163dfbdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a99691943f20bab0f36a5e329cc8730
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37995fbc12748a027702cb0683beb6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca3dcfa283fee3aac87d7262f0a8c836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e8ff61991c78fa412d3a1ee48cf77b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cb5e49cc428cdc08fa2b4ac0b51108b
publicationDate 2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004083600-A1
titleOfInvention Method of treating subterranean formations using mixed density proppants or sequential proppant stages
abstract An increase in effective propped lengths is evidenced in hydraulic fracturing treatments by the use of ultra lightweight (ULW) proppants. The ULW proppants have a density less than or equal to 2.45 g/cc and may be used as a mixture in a first proppant stage wherein at least one of the proppants is a ULW proppant. Alternatively, sequential proppant stages may be introduced into the formation wherein at least one of the proppant stages contain a ULW proppant and where at least one of the following conditions prevails: (i.) the density differential between the first proppant stage and the second proppant stage is greater than or equal to 0.2 g/cc; (ii.) both the first proppant stage and the second proppant stage contain a ULW proppant; (iii.) the rate of injection of the second proppant stage into the fracture is different from the rate of injection of the first proppant stage; or (iv.) the particle size of the second proppant stage is different from the particle size of the first proppant stage.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9919966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7207386-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7772163-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11008506-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9234415-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8714248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7757768-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133587-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7334635-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11111766-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7699106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012170522-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10988678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10041327-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003214-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8459353-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7726399-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015021523-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9388334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8689872-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8448706-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017065779-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938811-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7934557-B2
priorityDate 2003-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0773343-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3709300-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002048676-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID536387
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405794
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID36596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128666970
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID43891
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437376
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID43891
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID36596
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172281
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14828
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID32201
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66666
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID536387
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454486097
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID32201

Total number of triples: 73.